Is there real research on glutathione and skin?

Yes — enough for two systematic reviews in 2025, in the International Journal of Dermatology and Cureus, plus a 2019 review in the Journal of Cosmetic Dermatology.

What is the concern with intravenous use?

Safety, which is a stated focus of the 2025 Cureus review and has attracted regulatory attention in several jurisdictions.

Is glutathione approved for skin lightening?

No. It holds no marketing authorisation for that or any other purpose.

Glutathione

Glutathione and Skin Research

JMWritten & reviewed by Jack Muncaster · Founder, UK PeptidesLast reviewed 2026-08-233 cited sources

Two systematic reviews published in 2025 — Sarkar in the International Journal of Dermatology and Alzahrani in Cureus — examined glutathione as a skin-lightening agent. The literature exists and has been formally reviewed, and safety concerns about intravenous administration are a recurring theme in it.

Key facts

Sarkar 2025: Int J Dermatol, systematic review
Alzahrani 2025: Cureus, safety and efficacy review
Dilokthornsakul 2019: J Cosmet Dermatol, clinical effect
Proposed mechanism: Melanin synthesis pathway
Recurring concern: Intravenous administration safety
Marketing authorisation: None for this purpose

Why a review-level literature exists

Glutathione for skin lightening has been used widely enough, in enough places, to generate a body of clinical work worth reviewing systematically. Two such reviews appeared in 2025 — Sarkar and colleagues in the International Journal of Dermatology, covering skin-lightening and melasma, and Alzahrani and colleagues in Cureus on safety and efficacy. Dilokthornsakul and colleagues had reviewed clinical effects on skin colour in 2019.

The proposed mechanism

Melanin synthesis proceeds through an enzymatic pathway, and glutathione is described as interacting with it — both directly and through the shift from one melanin type toward another. This is a plausible biochemical rationale rather than a demonstrated mode of action in skin, and the reviews are the place to see how well the clinical data supports it.

Research material referenced

Glutathione 1500mg — third-party HPLC tested

View — £34.99

The safety question the reviews keep raising

Intravenous administration for cosmetic purposes has attracted specific regulatory attention in several jurisdictions, and safety is a stated focus of the 2025 Cureus review rather than an afterthought. When a review of a cosmetic intervention foregrounds safety, that is itself informative about the state of the practice.

What the review-level evidence is worth

Systematic reviews are stronger than individual studies because they assess the whole body of work including its quality. Two appearing in the same year suggests both continuing interest and unresolved questions — a settled matter does not generate simultaneous independent reviews.

What is being said and not said here

Reportable: that this literature exists, that it has been systematically reviewed in 2025, and that safety of intravenous use is a recurring concern within it. Not sayable, and not said: that glutathione lightens skin, treats melasma, or should be used for any cosmetic purpose. Glutathione holds no marketing authorisation for any of this.

Why this is the category's compliance pressure point

The commercial interest in glutathione is largely cosmetic, which means the gap between describing a literature and making a claim is narrower here than anywhere else in the catalogue. Material supplied here is for laboratory research and is not a cosmetic product.

Extended research context

The Glutathione deep dive

Deep dive: the bond that puts a peptide outside peptide biology

Glutamate is one of only two amino acids carrying two carboxyl groups - the backbone alpha-carboxyl every residue has, plus one on its side chain. Standard peptide bonds use the alpha. Glutathione uses the gamma, and that one choice cascades. Ribosomes have exactly one chemistry, in which an incoming residue's amine attacks the growing chain's alpha-carboxyl, and no mechanism whatsoever for recruiting a side chain. So glutathione cannot be a gene product. It is assembled instead by two ATP-dependent ligases, which means the genome encodes the machinery but never the molecule - a peptide present in nearly every cell of nearly every organism, with no coding sequence anywhere. The same geometry that excludes the ribosome also excludes most peptidases, whose active sites are built around the spacing of an alpha bond. Only gamma-glutamyl transpeptidase cleaves it, which puts turnover of a millimolar-concentration metabolite under the control of a single enzyme. Protease resistance by structural mismatch is more complete than anything proline achieves in a conventional peptide.

Deep dive: the one compound here where a purity figure does not tell you what you need

Every storage article on this site says disulfide chemistry is inapplicable, because KPV, Selank, TB-500, DSIP and Semax contain no cysteine at all. Glutathione is the compound those statements were implicitly excluding, and the exception is not marginal - its thiol is simultaneously the source of its function and its principal vulnerability. Two thiols meet, lose two hydrogens, and become GSSG at 612.6 Da. Oxygen drives it, trace metals catalyse it, no enzyme is required, and it proceeds in a vial left standing. The subtle part is that GSSG is not an impurity in the ordinary sense. It is correctly assembled glutathione in a different oxidation state, and a purity assay may well score it as related material rather than contamination. A preparation can be 99% pure and substantially oxidised at once. Where an experiment depends on the reduced form, the certificate does not answer the question - chromatography separating 307.33 from 612.6, or a thiol-specific assay, does.

Deep dive: the same question NAD+ raises, with better evidence and a less obvious answer

Both categories on this site face one structural question: does supplying the finished molecule work, or does it succeed only by being degraded to something the cell can actually use? For NAD+ the answer is fairly clearly the latter - 663 Da with two negative charges cannot cross a membrane, and CD38 degrades it outside the cell. For glutathione it is genuinely open, and the evidence is better. Richie and colleagues published a randomised controlled trial on body stores in the European Journal of Nutrition in 2015, reporting increases. But an increase in stores admits two readings: intact absorption and distribution, or degradation to glutamate, cysteine and glycine followed by resynthesis inside cells - in which case the useful contribution is essentially the cysteine, and the tripeptide is an expensive delivery vehicle for it. Since cysteine availability is what normally limits synthesis, and since gamma-glutamyl transpeptidase sits on intestinal surfaces waiting for exactly this substrate, the second reading is not a sceptical stretch. A store measurement alone cannot distinguish them.

Research applications

▸Cellular redox state measurement via GSH/GSSG ratio
▸Glutathione peroxidase and S-transferase enzyme assays
▸Oxidative stress model systems
▸Gamma-glutamyl transpeptidase activity studies
▸Thiol chemistry and disulfide exchange research
▸Melanin synthesis pathway investigation

Handling checklist

✓Verify against CID 124886, 307.33 Da, C10H17N3O6S
✓Check the oxidised form separately - GSSG is CID 65359 at 612.6 Da
✓Do not treat a purity figure as a statement about redox state
✓Store lyophilised, cold, dry; minimise headspace air
✓Prepare solutions fresh - thiol oxidation proceeds without any enzyme
✓Where the reduced form matters, assay free thiol rather than assuming

Common research-handling mistakes

Learnt from thousands of researcher orders across our UK labs.

✗ Assuming a high purity figure means the material is reduced

Fix: GSSG is correctly assembled glutathione in a different oxidation state. A purity assay may score it as related material, not contamination.

✗ Treating glutathione like the other peptides on this site

Fix: Its gamma bond makes it protease-resistant and non-ribosomal, and it is the only compound here with a reactive thiol. Most generalisations do not apply.

✗ Reading increased body stores as proof of intact absorption

Fix: Degradation to amino acids followed by intracellular resynthesis produces the same measurement. The trial endpoint cannot distinguish them.

✗ Citing the large biochemistry literature as evidence about supplementation

Fix: What glutathione does inside cells is settled. What supplementing it accomplishes is a separate and contested question.

✗ Repeating systematic review subject matter as a product claim

Fix: Describing what a literature examined and claiming a product does it are different acts. Only the first is permissible.

Continue researching

Peer-reviewed guides, comparators and matched reference materials.

Frequently asked questions

Is there real research on glutathione and skin?: Yes — enough for two systematic reviews in 2025, in the International Journal of Dermatology and Cureus, plus a 2019 review in the Journal of Cosmetic Dermatology.
What is the concern with intravenous use?: Safety, which is a stated focus of the 2025 Cureus review and has attracted regulatory attention in several jurisdictions.
Is glutathione approved for skin lightening?: No. It holds no marketing authorisation for that or any other purpose.

Primary sources & clinical trials

Peer-reviewed research and registered trials from PubMed, ClinicalTrials.gov, PubChem, FDA and NIH. All links open in a new tab and point to the primary source, so every claim can be verified at origin.

Written and reviewed by

Jack Muncaster · Founder, UK Peptides

Jack founded UK Peptides in Manchester after repeatedly receiving research compounds with missing or recycled paperwork. He is responsible for supplier selection, batch release decisions and the content published in this research library. Every article here is sourced to primary literature and every product page to a signed third-party certificate.

How we write and check this content Report a factual error in this article

Popular across the research hub

One flagship guide from every other research category — keep exploring.

← Back to Forum